Gabapentin Capsule
Product Images NDC 80425-0196

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

FDA Label Image

Label 3 (Label 3)

Label 3 (Label 3)
This appears to be a partial text containing information on a medication called Gabapentin in 300mg capsules that comes in a bottle of 90 and can be compared to a similar medication called Neurontin. The text also includes an NDC and source number, as well as an expiration date of 11/11/2013. There is also a line of unclear characters that cannot be properly evaluated.*
FDA Label Image

Label 1 (Lable 1)

FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
This is a bottle containing 60 capsules of Gabapentin 300mg. The source of the medication is NOC with the code 69367-034-05. The medication has an expiration date of November 1, 2023. There is also a serial number listed as SN 000000115209.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
The text shows a table with three columns representing the "Mean Pain Score" for different periods of a study. The study had a "d-Week Dose Titration Period" followed by a "4-Week Fixed Dose Period". The rows of the table show the pain score for different timepoints (Baseline, 1, 2, 3, 4, 5, 6, 7) for two groups: Placebo and Gabapentin (taken at a dose of 3,600 mg/day).*
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
The text describes a table that displays mean pain scores over a 4-week period. There are three groups: a placebo group, a group receiving 1800mg/day of gabapentin, and a group receiving 2400mg/day of gabapentin. The baseline pain score and scores at weeks 1-7 are included.*
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
The text seems to be a table or graph with percentages and statistical notations. It is difficult to provide a description without additional context or information.*
FDA Label Image

Fig 4 (Fig 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.